Human Embryonic Stem Cell-Derived Mesodermal Progenitors for Bone Engineering

  • Giuseppe Maria de Peppo
  • Camilla Karlsson
Part of the Stem Cells and Cancer Stem Cells book series (STEM, volume 7)


Stem cells display the unique properties of self-renewal and different degrees of potency for differentiation into various cell types. Stem cells derived from human embryos, or generated via reprogramming technology of somatic cells, can divide indefinitely and give rise to virtually all cell types constituting the human body under proper conditions (pluripotency). The high regenerative potential of human embryonic stem cells makes them an exceptional tool with unprecedented potential for investigational and therapeutic applications, such as for example in stem cell-based tissue engineering. However, the stemness phenotype of human embryonic stem cells is associated with their ability to form teratomas after in vivo transplantation, which is currently representing a major obstacle to their translational use into clinical practice. An alternative is the use of human embryonic stem cells as source for the derivation of renewable progenitor cells, which display lineage commitment restriction but lack the potential to form teratoma. Using different experimental strategies several human embryonic stem cell-derived progenitors have been established recently, including mesodermal progenitor cells displaying mesenchymal-like properties and high potential for the construction of functional substitutes for bone replacement therapies. However, relatively few experimental studies have been reported to date and further rigorous investigation is required to validate their functionality in vivo and assess their safety for possible future clinical applications.


Pluripotent Stem Cell Human Embryonic Stem Cell Bone Substitute Inner Cell Mass Osteogenic Lineage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Ahn SE, Kim S, Park KH, Moon SH, Lee HJ, Kim GJ, Lee YJ, Park KH, Cha KY, Chung HM (2006) Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun 340:403–408PubMedCrossRefGoogle Scholar
  2. Barberi T, Willis LM, Socci ND, Studer L (2005) Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2:e161PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bigdeli N, Andersson M, Strehl R, Emanuelsson K, Kilmare E, Hyllner J, Lindahl A (2008) Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces. J Biotechnol 133:146–153PubMedCrossRefGoogle Scholar
  4. Bigdeli N, de Peppo GM, Lennerås M, Sjövall P, Lindahl A, Hyllner J, Karlsson C (2010) Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng Part A 16:3427–3440PubMedCrossRefGoogle Scholar
  5. Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL (2009) Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A 15:1897–1907PubMedCentralPubMedCrossRefGoogle Scholar
  6. Cao T, Heng BC, Ye CP, Liu H, Toh WS, Robson P, Li P, Hong YH, Stanton LW (2005) Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 37:325–334PubMedCrossRefGoogle Scholar
  7. De Bruyn PP, Kabisch WT (1955) Bone formation by fresh and frozen, autogenous and homogenous transplants of bone, bone marrow and periosteum. Am J Anat 96:375–417CrossRefGoogle Scholar
  8. de Peppo GM (2011) Human embryonic stem cells for bone engineering applications.
  9. de Peppo GM, Svensson S, Lennerås M, Synnergren J, Stenberg J, Strehl R, Hyllner J, Thomsen P, Karlsson C (2010a) Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A 16:2161–2182PubMedCrossRefGoogle Scholar
  10. de Peppo GM, Sjovall P, Lennerås M, Strehl R, Hyllner J, Thomsen P, Karlsson C (2010b) Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A 16:3413–3426PubMedCrossRefGoogle Scholar
  11. Fong CY, Gauthaman K, Bongso A (2010) Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem 111:769–781PubMedCrossRefGoogle Scholar
  12. Hwang NS, Varghese S, Lee HJ, Zhang Z, Ye Z, Bae J, Cheng L, Elisseeff J (2008) In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 105:20641–20646PubMedCentralPubMedCrossRefGoogle Scholar
  13. Inanc B, Elcin AE, Elcin YM (2007) Effect of osteogenic induction on the in vitro differentiation of human embryonic stem cells cocultured with periodontal ligament fibroblasts. Artif Organs 31:792–800PubMedCrossRefGoogle Scholar
  14. Karlsson C, Emanuelsson K, Wessberg F, Kajic K, Axell MZ, Eriksson PS, Lindahl A, Hyllner J, Strehl R (2009) Human embryonic stem cell-derived mesenchymal progenitors-potential in regenerative medicine. Stem Cell Res 3(1):39–50PubMedCrossRefGoogle Scholar
  15. Kim S, Kim SS, Lee SH, Eun Ahn S, Gwak SJ, Song JH, Kim BS, Chung HM (2008) In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(D, L-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials 29:1043–1053PubMedCrossRefGoogle Scholar
  16. Lee EJ, Lee HN, Kang HJ, Kim KH, Hur J, Cho HJ, Lee J, Chung HM, Cho J, Cho MY, Oh SK, Moon SY, Park YB, Kim HS (2010) Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A 16:705–715PubMedCrossRefGoogle Scholar
  17. Lian Q, Lye E, Suan Yeo K, Khia Way Tan E, Salto-Tellez M, Liu TM, Palanisamy N, El Oakley RM, Lee EH, Lim B, Lim SK (2007) Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 25:425–436PubMedCrossRefGoogle Scholar
  18. Liu Y, Hemattia P (2009) Generation of mesenchymal stromal cells from a HOXB4-expressing human embryonic stem cells colony. Cytotherapy 11(6):716–725PubMedCentralPubMedCrossRefGoogle Scholar
  19. Mahmood A, Harkness L, Schrøder HD, Abdallah BM, Kassem M (2010) Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 25:1216–1233PubMedCrossRefGoogle Scholar
  20. Olivier EN, Rybicki AC, Bouhassira EE (2006) Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24:1914–1922PubMedCrossRefGoogle Scholar
  21. Seeley R, Stephens T, Tate P (2006) Anatomy & physiology. McGraw-Hill, New YorkGoogle Scholar
  22. Shimko DA, Burks CA, Dee KC, Nauman EA (2004) Comparison of in vitro mineralization by murine embryonic and adult stem cells cultured in an osteogenic medium. Tissue Eng 10:1386–1398PubMedCrossRefGoogle Scholar
  23. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147PubMedCrossRefGoogle Scholar
  24. Tian XF, Heng BC, Ge Z, Lu K, Rufaihah AJ, Fan VT, Yeo JF, Cao T (2008) Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems. Scand J Clin Lab Invest 68:58–67PubMedCrossRefGoogle Scholar
  25. Ullmann U, In’t Veld P, Gilles C, Sermon K, De Rycke M, Van de Velde H, Van Steirteghem A, Liebaers I (2007) Epithelial–mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod 13:21–32PubMedCrossRefGoogle Scholar
  26. Xu C, Jiang J, Sottile V, McWhir J, Lebkowski J, Carpenter MK (2004) Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22:972–980PubMedCrossRefGoogle Scholar
  27. Yang M, Liu L (2008) MHC II gene knockout in tissue engineering may prevent immune rejection of transplants. Med Hypotheses 70:798–801PubMedCrossRefGoogle Scholar
  28. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  1. 1.Department of BiomaterialsSahlgrenska Academy at University of GothenburgGöteborgSweden

Personalised recommendations